Beate Aue

Title: Beate Aue: Innovator in Growth Hormone Assessment

Introduction

Beate Aue is a notable inventor based in Aschaffenburg, Germany. She has made significant contributions to the field of medical diagnostics, particularly in assessing growth hormone deficiency in children. Her innovative approach has the potential to improve the accuracy of diagnoses and treatment plans for pediatric patients.

Latest Patents

Beate Aue holds a patent for the invention titled "Use of macimorelin in assessing growth hormone deficiency in children." This patent describes a method for measuring growth hormone levels in human children. The method involves the oral administration of an effective amount of macimorelin, followed by the collection of two or three post-administration blood samples within approximately 60 minutes. The growth hormone levels in these samples are then determined to diagnose pituitary-related growth hormone deficiency when the peak level is below a specified cut-off value. This innovative method offers a stand-alone test for assessing growth hormone levels in children.

Career Highlights

Beate Aue is associated with Æterna Zentaris GmbH, where she has been instrumental in advancing research and development in the field of endocrinology. Her work has focused on creating effective diagnostic tools that can enhance patient care and treatment outcomes.

Collaborations

Beate collaborates with esteemed colleagues such as Nicola Ammer and Michael Teifel. Their combined expertise contributes to the innovative research and development efforts at Æterna Zentaris GmbH.

Conclusion

Beate Aue's contributions to the field of growth hormone assessment represent a significant advancement in pediatric medicine. Her innovative patent and collaborative efforts highlight her commitment to improving diagnostic methods for children.